Evidence map›Paper›PMID 23071728›Full record

ArticlePloS one2012

The eIF4E-binding protein Eap1p functions in Vts1p-mediated transcript decay.

Laura M Rendl, Melissa A Bieman, Heli K Vari, Craig A Smibert

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Med9 Is a Novel eIF4E-Interacting Protein inInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. eIF4E and Interactors from Unicellular Eukaryotes.International journal of molecular sciences · 2020
    Review
  5. Review
  6. Article
  7. Article
  8. Comprehensive and quantitative mapping of RNA-protein interactions across a transcribed eukaryotic genome.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Laura M RendlDepartment of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Melissa A Bieman
Heli K Vari
Craig A Smibert
University of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sequence-specific RNA binding proteins can induce the degradation of mRNAs through their ability to recruit proteins that trigger transcript destabilization. For example, Vts1p, the S. cerevisiae member of the Smaug family of RNA binding proteins, is thought to induce transcript decay by recruiting the Ccr4p-Pop2p-Not deadenylase complex to target mRNAs. The resulting deadenylation triggers transcript decapping followed by 5'-to-3' exonucleolytic decay. Here we show that the eIF4E-binding protein, Eap1p, is required for efficient degradation of Vts1p target transcripts and that this role involves the ability of Eap1p to interact with eIF4E. Eap1p does not stimulate deadenylation of Vts1p target transcripts but is instead involved in decapping. Eap1p interacts with Vts1p and mediates an indirect interaction between Vts1p and eIF4E. Taken together these data suggest a model whereby the interaction of Vts1p with Eap1p at target mRNAs stimulates decapping.

Indexed as

RNA StabilityEukaryotic Initiation Factor-4EProtein BindingRNA-Binding ProteinsRNA CapsRNA, MessengerSaccharomyces cerevisiae ProteinsTranscription FactorsEap1 protein, S cerevisiaeEukaryotic Initiation Factor-4ERNA-Binding ProteinsRNA CapsRNA, MessengerSaccharomyces cerevisiae ProteinsTranscription FactorsVts1 protein, S cerevisiae

Identifiers

PMID23071728
PMCPMC3468468
OpenAlexW1998335195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.